Open AccessThe future of adjuvant therapy in ampullary cancer: should we offer it to our patients?
Author(s) -
Sri Harsha Tella,
Amit Mahipal
Publication year - 2020
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2019.11.06
Subject(s) - medicine , incidence (geometry) , epidemiology , adjuvant therapy , cancer , gastrointestinal tract , gastrointestinal cancer , adjuvant , oncology , cancer incidence , general surgery , colorectal cancer , physics , optics
Ampullary carcinoma is a relatively rare and heterogenous neoplasm accounting for 0.2% of all gastrointestinal tract malignancies. The data from National Cancer Institute’s Surveillance, Epidemiology, and End Results Program have shown an increase in incidence of ampullary cancer over the last decade (1).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom